Table 2. Meta-analysis of adverse events.
| Adverse events | Number of included studies | Heterogeneity (I2) | OR (95% CI) | P |
|---|---|---|---|---|
| nausea/vomiting | 4 | 59% | 0.363 (0.259,0.476) | 0.02 |
| hypoleukemia | 4 | 75% | 0.194 (0.099,0.359) | 0.0008 |
| neutropenia | 4 | 78% | 0.160 (0.083,0.286) | <0.0001 |
| increased creatinine | 4 | 0% | 0.099 (0.065, 0.160) | <0.00001 |
| increased alanine aminotransferase | 3 | 0% | 0.187 (0.130,0.265) | <0.00001 |
| thrombocytopenia | 3 | 83% | 0.099 (0.029,0.275) | 0.0004 |
Notes.
- I2
- I- squared test
- OR
- odds ratio
- 95% CI
- 95% confidence intervals (CIs)